Multiple studies have shown that African American women with breast cancer have lower survival rates than white women with the disease. But the association between race or ethnicity and treatment outcomes in triple-negative breast cancer—an aggressive type of tumor that does not respond to hormonal or other targeted therapies—has not been well defined.